RxDoctor Payments Data

Wondiful Colbert, MD

Family Medicine · New Canton, VANPI 1548248636

Payments from drug & device makers

$3,200in general payments, 2019–2025

Across 175 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$808
  • Lilly USA, LLC$316
  • Pfizer$266
  • AbbVie$202
  • Boehringer Ingelheim$194
  • AstraZeneca$160
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,200100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,200 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$78,925
Medicare patients
215
Services billed
919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide130$141,475
JardianceEmpagliflozin58$58,575
MounjaroTirzepatide36$56,461
TrulicityDulaglutide33$41,174
JanuviaSitagliptin Phosphate35$37,521
RybelsusSemaglutide31$32,962
FarxigaDapagliflozin Propanediol22$23,889
Repatha SureclickEvolocumab13$13,280
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$12,753
TradjentaLinagliptin13$11,842
LinzessLinaclotide15$11,113
Synjardy XrEmpagliflozin/Metformin Hcl11$10,633
Janumet XrSitagliptin Phos/Metformin Hcl11$6,200
NexletolBempedoic Acid15$5,922
Rosuvastatin Calcium361$3,926

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$808$174,437161 claims
Lilly USA, LLCMounjaro, Trulicity$316$97,63569 claims
Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr$194$81,05082 claims
MerckJanuvia, Janumet Xr$125$43,72146 claims
AstraZenecaFarxiga$160$23,88922 claims
GSKTrelegy Ellipta$84$12,75320 claims
AbbVieLinzess, Synthroid$202$12,29341 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in New Canton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →